Company: ARTL
Filing Date: 2025-05-13
Form Type: 10-Q
Source: 0001640334-25-000825
Chunk: 108

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-05-13
Form: 10-Q
Item: Part II, Item 5
Chunk 108
---
Securities Trading Plans of Directors and Executive Officers

During our last fiscal quarter, none of our directors or officers, as defined in Rule 16a-1(f), adopted and/or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as defined in Regulation S-K Item 408. 

 53Table of Contents

Item 6. Exhibits

ExhibitNumber Description Form File No. FilingDate FiledHerewith3.1 Articles of Incorporation, as amended 10-Q  001-38951  05/11/2023  3.2 Amended and Restated Bylaws  8-K 001-38951  04/21/2023 31.1 Section 302 Certification       *32.1 ** Section 906 Certification       *101. INS Inline XBRL Instance Document        101. SCH Inline XBRL Taxonomy Extension Schema Document        101. CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document        101. DEF Inline XBRL Taxonomy Extension Definition Linkbase Document        101. LAB Inline XBRL Taxonomy Extension Label Linkbase Document        101. PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document        104 Cover page Interactive Data File (embedded with the Inline XBRL document)        

___________

** The certification attached as Exhibit 32.1 that accompanies this Quarterly Report on Form 10-Q, is deemed furnished and not filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Artelo Biosciences, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.

 54Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. 

 Artelo Biosciences, Inc. (Registrant)   Dated: May 13, 2025 /s/ Gregory D. Gorgas Gregory D. Gorgas President, Chief Executive